西澳2002-2019年ACS亚型30天存活者长期心血管结局
该研究基于西澳2002-2019年链接住院与死亡数据,纳入73 321例ACS 30天存活者,评估STEMI、NSTEMI与UA的5年MACE及全因死亡累积发生率,并用Cox模型分析关联。结果显示NSTEMI远期MACE与死亡风险最高,各亚型调整后风险在整个研究期内均无随时间改善。
要点
- NSTEMI的5年MACE率29.7%,高于STEMI的19.4%和UA的19.9%。
- NSTEMI全因死亡率29.8%,高于STEMI的15.9%和UA的17.2%。
- 各ACS亚型调整后结局风险在研究期间未见时间性改善。
核心结论
- 30天存活的所有ACS亚型患者远期MACE与全因死亡风险仍高,且近年未见改善。
- 长期监测与优化二级预防对所有ACS亚型存活者均重要。
研究设计与样本
- 基于西澳链接住院与死亡数据的回顾性队列研究。
- 纳入2002-2019年首次因STEMI、NSTEMI或UA住院的30天存活者,共73 321例。
- 采用Cox比例风险模型调整潜在混杂因素后分析关联。
主要发现
- 队列中男性占65%,STEMI占22.3%,NSTEMI占43.2%,UA占34.6%。
- STEMI、NSTEMI、UA平均年龄分别为63.2、68.8、66.4岁。
- NSTEMI与UA患者较STEMI更可能为女性且合并更多合并症。
- 5年MACE累积率:NSTEMI 29.7% vs STEMI 19.4% vs UA 19.9%(log-rank p<0.001)。
- 5年全因死亡率:NSTEMI 29.8% vs STEMI 15.9% vs UA 17.2%(log-rank p<0.001)。
临床怎么用
- 对ACS 30天存活者应重视长期随访与二级预防,NSTEMI患者风险尤其突出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite advances in acute coronary syndrome (ACS) management, contemporary data assessing long-term prognosis after ST-segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) and unstable angina (UA) are scarce. METHODS: Linked hospitalisation and mortality data identified all 30-day survivors of index STEMI, NSTEMI and UA hospitalisation in Western Australia between 2002 and 2019. We assessed the cumulative 5-year incidence of major adverse cardiovascular events (MACE), comprising non-fatal MI, stroke, heart failure hospitalisation or cardiovascular death and separately all-cause death in 30-day survivors of index ACS hospitalisation. Associations were examined using Cox proportional hazards modelling after adjustment for potential confounders. RESULTS: The cohort totalled 73 321 patients with ACS, 65% males, 22.3% with STEMI, 43.2% NSTEMI and 34.6% UA with mean age 63.2, 68.8 and 66.4 years, respectively. Patients with NSTEMI and UA compared with STEMI were more likely to be female with additional comorbidities. Cumulative 5-year MACE rates after NSTEMI were 29.7% vs 19.4% and 19.9% after STEMI and UA, respectively (log-rank p<0.001), while all-cause mortality was 29.8% vs 15.9% and 17.2%, respectively (log-rank p<0.001). There was no temporal improvement in multivariable-adjusted risk of outcomes for all ACS subtypes throughout the study period. The adjusted HRs for MACE and all-cause death were 1.5-fold or higher in males and females with STEMI or NSTEMI versus UA. CONCLUSIONS: Long-term risk of MACE and all-cause death remains high and unchanged among 30-day survivors of all ACS subtypes in the recent era. Long-term surveillance and optimal secondary prevention are important in survivors of all ACS subtypes.
引用
- Hung, Fudge, Lopez, et al. Long-term cardiovascular outcomes in patients hospitalised with acute coronary syndrome subtypes in Western Australia, 2002-2019. Heart. 2026. PMID: 42349938. doi:10.1136/heartjnl-2026-327843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。